Laurie Renelle Margolies

Dr. Laurie Renelle Margolies


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2018 in Current Radiology Reports
Verified
Journal Article
Open access
PDF file
KLKaren A. Lee
Karen A. Lee
NTNishi Talati
Nishi Talati
RORebecca Oudsema
Rebecca Oudsema
SSSharon Steinberger
Sharon Steinberger
LMLaurie Renelle Margolies
Laurie Renelle Margolies
Purpose of Review Probably benign (BI-RADS 3) causes confusion for interpreting physicians and referring physicians and can induce significant patient anxiety. The best uses and evidence for using this assessment category in mammography, breast ultrasound, and breast MRI will be reviewed; the reader will have a better understanding of how and when to use BI-RADS 3. Recent Findings Interobserver variability in the use of BI-RADS 3 has been documented. The 5th edition of the BI-RADS atlas details the appropriate use of BI-RADS 3 for diagnostic mammography, ultrasound, and MRI, and discourages its use in screening mammography. Data mining, elastography, and diffusion weighted MRI have been evaluated to maximize the accuracy of BI-RADS 3. Summary BI-RADS 3 is an evolving assessment category. When used properly, it reduces the number of benign biopsies while allowing the breast imager to maintain a high sensitivity for the detection of early stage breast cancer.

1 February 2016 in American Journal of Roentgenology
Verified
Journal Article
Closed access
LMLaurie Renelle Margolies
Laurie Renelle Margolies
GPGaurav Pandey
Gaurav Pandey
EHEliot R. Horowitz
Eliot R. Horowitz
DMDavid S. Mendelson
David S. Mendelson
OBJECTIVE. The purpose of this article is to describe structured reporting and the development of large databases for use in data mining in breast imaging. CONCLUSION. The results of millions of breast imaging examinations are reported with structured tools based on the BI-RADS lexicon. Much of these data are stored in accessible media. Robust computing power creates great opportunity for data scientists and breast imagers to collaborate to improve breast cancer detection and optimize screening algorithms. Data mining can create knowledge, but the questions asked and their complexity require extremely powerful and agile databases. New data technologies can facilitate outcomes research and precision medicine.

1 March 2015 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
VYVivian M. Yeh
Vivian M. Yeh
JSJulie B. Schnur
Julie B. Schnur
LMLaurie Renelle Margolies
Laurie Renelle Margolies
GMGuy H. Montgomery
Guy H. Montgomery

2 May 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
SSStephanie B Shamir
Stephanie B Shamir
ASArielle Sasson
Arielle Sasson
LMLaurie Renelle Margolies
Laurie Renelle Margolies
DMDavid S. Mendelson
David S. Mendelson
Artificial intelligence (AI) has been implemented in multiple fields of medicine to assist in the diagnosis and treatment of patients. AI implementation in radiology, more specifically for breast imaging, has advanced considerably. Breast cancer is one of the most important causes of cancer mortality among women, and there has been increased attention towards creating more efficacious methods for breast cancer detection utilizing AI to improve radiologist accuracy and efficiency to meet the increasing demand of our patients. AI can be applied to imaging studies to improve image quality, increase interpretation accuracy, and improve time efficiency and cost efficiency. AI applied to mammography, ultrasound, and MRI allows for improved cancer detection and diagnosis while decreasing intra- and interobserver variability. The synergistic effect between a radiologist and AI has the potential to improve patient care in underserved populations with the intention of providing quality and equitable care for all. Additionally, AI has allowed for improved risk stratification. Further, AI application can have treatment implications as well by identifying upstage risk of ductal carcinoma in situ (DCIS) to invasive carcinoma and by better predicting individualized patient response to neoadjuvant chemotherapy. AI has potential for advancement in pre-operative 3-dimensional models of the breast as well as improved viability of reconstructive grafts.

1 April 2021 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
JFJenny Fung
Jenny Fung
SVSuzanne Vang
Suzanne Vang
LMLaurie Renelle Margolies
Laurie Renelle Margolies
ALAlicia Li
Alicia Li
EBEsther Blondeau-Lecomte
Esther Blondeau-Lecomte
LJLina Jandorf
Lina Jandorf

3 March 2014 in ISRN Radiology
Verified
Journal Article
Open access
PDF file
LMLaurie Renelle Margolies
Laurie Renelle Margolies
ACA. Cohen
A. Cohen
ESE. Sonnenblick
E. Sonnenblick
JMJ. Mandeli
J. Mandeli
PSP. H. Schmidt
P. H. Schmidt
EPE. Port
E. Port
Objectives. To study factors that predict changes in management with digital breast tomosynthesis (DBT). Methods. The Institutional Review Board approved this HIPAA compliant study. 996 patients had DBT with full field digital mammography (FFDM). Univariate analysis evaluated predictors of management change and cancer detection. Results. DBT changed management in 109 of 996 (11%); 77 (71%) required less imaging. Recalled patients after abnormal FFDM screen were most likely to have management change—25% (24 of 97 patients) compared to 8% (13/163) of symptomatic patients and 10% (72/736) of screening patients (). Dense breasted patients had a higher likelihood of having DBT change management: 13% (68/526) compared to 9% (41/470) (). Of the 996 patients, 19 (2%) were diagnosed with breast cancer. 15 cancers (83%) were seen on FFDM and DBT; 3 (17%) were diagnosed after DBT (0.3%, 95%CI: 0.1–0.9%). One recurrence was in the skin and was not seen on DBT nor was it seen on FFDM. The increase in cancer detection rate was 17% for asymptomatic patients, 0% for symptomatic patients, and 100% for recalled patients. Conclusions. DBT increased cancer detection rate by 20% and decreased the recall rate in 8–25%. Advances in Knowledge. DBT led to a doubling of the cancer detection rate in recalled patients.